Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Ivan Ahel, Adrian Hill and Yang Shi on their election to the membership of the European Molecular Biology Organization (EMBO)

EMBO announces that 67 researchers have been elected to its membership. Through this lifelong honour, new EMBO Members and Associate Members are recognised for their outstanding achievements in the life sciences.

Three new EMBO members have been elected from Oxford:

  • Dr Ivan Ahel (Sir William Dunn School of Pathology) studies pathways and protein functions underlying genome stability, which are regulated by a type of protein and DNA modification called ADP-ribosylation.
  • Professor Adrian Hill (Jenner Institute) leads research into vaccines for malaria and other major diseases such as COVID-19 and cancer.
  • Professor Yang Shi (Ludwig Institute for Cancer Research) is recognised by EMBO for his significant contributions to epigenetic research, which explores how chemical modifications made to chromatin influence the organisation and expression of the human genome.

EMBO has in its membership 1,900 eminent scientists elected by their peers to promote excellence in the life sciences in Europe and beyond. Altogether, 90 Nobel laureates have been members of the organisation since it was established in 1964. Ahel, Hill and Shi are three of 58 new members elected to the organisation this year, along with nine associate members working in seven countries outside Europe.

 

The new EMBO Members and Associate Members are exceptional scientists, who carry out leading research across a variety of fields, ranging from cell biology and cancer to vaccine development and machine learning. I am delighted to welcome them to EMBO, and I know that they will enrich the life of the organization immensely. - EMBO Director Fiona Watt

EMBO will formally welcome the new members at the annual Members’ Meeting in Heidelberg between 26 and 28 October 2022.

Similar Stories

Eileen Parkes awarded Wellcome Clinical Research Career Development Fellowship

Eileen will investigate the expression of genetic instability and how it shapes the immune microenvironment of oesophageal cancers.

Dr Heba Sailem wins international award for work on cancer gene functions

The Swiss Institute of Bioinformatics has recognised the work of research fellow Dr Heba Sailem with the Early Bioinformatician Award.

Impact award for publication on ovarian cancer

A paper led by Dr Zhiyuan Hu from Professor Ahmed Ahmed’s lab has won the Columbia Hospital for Women Research Foundation’s 2020-2021 prize for impact.